Select a Contributor Response

Conversations:

What do you think the most important thing a potential clinical trial participant should know about clinical research when they are deciding whether to participate? What does clinical research mean to you?

View All Conversations

 

What do you think the most important thing a potential clinical trial participant should know about clinical research when they are deciding whether to participate? What does clinical research mean to you?

Test Name
Test Title, Test Company

Read biography×
This is a test modal

Sultan on ACS-CAN event

Submitted by Ali on

House on ACS-CAN event

Submitted by Ali on

Nasso on ACS-CAN event

Submitted by Ali on

Select a Contributor Response

Conversations:

Cancer care advocates share their thoughts on payment and delivery reform.

View All Conversations

 

Cancer care advocates share their thoughts on payment and delivery reform.

Test Name
Test Title, Test Company

Read biography×
This is a test modal

Saira Sultan
,


Shelly Fuld Nasso
,


Hinojosa on Minority Health

In looking at avenues to support minority health initiatives, particularly in the Hispanic community, it is essential to develop relationships with trusted leaders within the community. Organizations, religious institutions, local businesses, and community health centers are where advocates with real community touch points can be found. These leaders will be central to sharing safe, reliable information with their friends, neighbors and clients.

Ko Chin on Minority Health

When we think about improving minority health, we rarely think of clinical trials and research. But we should. To move closer to health equity, we must increase the participation of diverse communities in clinical trials.

Clinical trials are essential in determining whether a drug is ready for mass consumption, as well as revealing important information for doctors and patients about prevention, diagnostic and treatment methods. They can also help shed light on whether there are unique bio-markers across the different groups the product is being provided to.

Kathy Ko Chin
,


Pages

Subscribe to PhRMA RSS